Medifast (MED) Depreciation & Amortization (CF) (2010 - 2026)

Medifast's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 6.19% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.4 million (up 13.51% YoY) and the FY2025 annual result came in at $14.2 million, up 12.08% from the prior year.
• Depreciation & Amortization (CF) was $3.5 million for Q1 2026 at Medifast, up from $3.5 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $4.0 million in Q2 2025 and bottomed at $2.4 million in Q1 2022.
• A 5-year average of $3.2 million and a median of $3.3 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 117.44% — and 2024, when it declined 8.94%.
• Medifast's Depreciation & Amortization (CF) stood at $3.0 million in 2022, then climbed by 13.51% to $3.4 million in 2023, then dropped by 5.01% to $3.2 million in 2024, then increased by 8.79% to $3.5 million in 2025, then grew by 0.52% to $3.5 million in 2026.
• Business Quant data shows MED's Depreciation & Amortization (CF) at $3.5 million in Q1 2026, $3.5 million in Q4 2025, and $3.5 million in Q3 2025.